- Reports /
- Hollow Fiber Filtration Market
Hollow Fiber Filtration Market
Hollow Fiber Filtration Market Market Research Report – Segmented By Material (Polymeric, Ceramic), By Technique (Microfiltration, Ultrafiltration), By Application (Continuous Cell Perfusion, Harvest and Clarification, Concentration and Diafiltration), By End User (Pharmaceutical and Biotechnology Manufacturers, Contract Research and Manufacturing Organizations, R&D Departments, Other End Users), By Region (North America, Europe, Asia Pacific, Rest of the World) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Material
- By Technique
- By Application
- By End User
- By Region
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Hollow Fiber Filtration Market was valued at US $447.10 million in 2021 and is projected to grow at 26.21% CAGR over the forecast period to reach US $1,807.20 million by 2027. Hollow Fiber Filtration Market represented US $166.43 million opportunity over 2019-2021 and estimated to create US $1,360.09 million opportunity in 2027 over 2021.
Hollow Fiber Filtration from Consainsights analyses the Hollow Fiber Filtration Market in the Life Sciences industry over the forecast period to 2027.
Hollow Fiber Filtration research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Hollow Fiber Filtration segmentation includes Material, Technique, Application, End User, Region and Geography.
Based on the Material, the Hollow Fiber Filtration analysis covers Polymeric, Ceramic.
In Material segment, Polymeric segment has highest cagr growth of 22.99%.
Based on the Technique, the Hollow Fiber Filtration analysis covers Microfiltration, Ultrafiltration.
In Technique segment, Ultrafiltration segment has highest cagr growth of 22.99%.
Based on the Application, the Hollow Fiber Filtration analysis covers Continuous Cell Perfusion, Harvest and Clarification, Concentration and Diafiltration.
In Application segment, Continuous Cell Perfusion segment has highest cagr growth of 22.99%.
Based on the End User, the Hollow Fiber Filtration analysis covers Pharmaceutical and Biotechnology Manufacturers, Contract Research and Manufacturing Organizations, R&D Departments, Other End Users.
In End User segment, Pharmaceutical and Biotechnology Manufacturers segment has highest cagr growth of 22.99%.
Based on the Region, the Hollow Fiber Filtration analysis covers North America, Europe, Asia Pacific, Rest of the World.
In Region segment, North America segment has highest cagr growth of 22.99%.
Based on the region, the Hollow Fiber Filtration analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Asahi Kasei Corporation, Repligen Corporation, GE Healthcare, Danaher Corporation, Parker-Hannifin Corporation, Koch Membrane Systems, Inc., Watersep Bioseparation Corporation, Toyobo Co., Ltd., Microdyn-Nadir GmbH, Cantel Medical Corporation, Coorstek, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Material
Introduction
In 2021, Polymeric segment has the highest revenue of US $336.49 million and is expected to grow at CAGR of 22.99% by 2027 Polymeric segment has highest cagr growth of 22.99%.
Polymeric
Polymeric segment was valued at US $211.24 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $1,360.10 million by 2027. Polymeric segment represented US $125.25 million opportunity over 2019-2021 and estimated to create US $1,023.61 million opportunity in 2027 over 2021.
Ceramic
Ceramic segment was valued at US $69.44 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $447.09 million by 2027. Ceramic segment represented US $41.17 million opportunity over 2019-2021 and estimated to create US $336.48 million opportunity in 2027 over 2021.
Technique
Introduction
In 2021, Microfiltration segment has the highest revenue of US $294.64 million and is expected to grow at CAGR of 22.99% by 2027 Ultrafiltration segment has highest cagr growth of 22.99%.
Microfiltration
Microfiltration segment was valued at US $184.97 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $1,190.95 million by 2027. Microfiltration segment represented US $109.67 million opportunity over 2019-2021 and estimated to create US $896.31 million opportunity in 2027 over 2021.
Ultrafiltration
Ultrafiltration segment was valued at US $95.71 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $616.25 million by 2027. Ultrafiltration segment represented US $56.75 million opportunity over 2019-2021 and estimated to create US $463.79 million opportunity in 2027 over 2021.
Application
Introduction
In 2021, Continuous Cell Perfusion segment has the highest revenue of US $276.05 million and is expected to grow at CAGR of 22.99% by 2027 Continuous Cell Perfusion segment has highest cagr growth of 22.99%.
Continuous Cell Perfusion
Continuous Cell Perfusion segment was valued at US $173.30 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $1,115.81 million by 2027. Continuous Cell Perfusion segment represented US $102.75 million opportunity over 2019-2021 and estimated to create US $839.75 million opportunity in 2027 over 2021.
Harvest and Clarification
Harvest and Clarification segment was valued at US $89.01 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $573.08 million by 2027. Harvest and Clarification segment represented US $52.77 million opportunity over 2019-2021 and estimated to create US $431.30 million opportunity in 2027 over 2021.
Concentration and Diafiltration
Concentration and Diafiltration segment was valued at US $18.38 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $118.31 million by 2027. Concentration and Diafiltration segment represented US $10.90 million opportunity over 2019-2021 and estimated to create US $89.04 million opportunity in 2027 over 2021.
End User
Introduction
In 2021, Pharmaceutical and Biotechnology Manufacturers segment has the highest revenue of US $218.69 million and is expected to grow at CAGR of 22.99% by 2027 Pharmaceutical and Biotechnology Manufacturers segment has highest cagr growth of 22.99%.
Pharmaceutical and Biotechnology Manufacturers
Pharmaceutical and Biotechnology Manufacturers segment was valued at US $137.29 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $883.95 million by 2027. Pharmaceutical and Biotechnology Manufacturers segment represented US $81.40 million opportunity over 2019-2021 and estimated to create US $665.26 million opportunity in 2027 over 2021.
Contract Research and Manufacturing Organizations
Contract Research and Manufacturing Organizations segment was valued at US $69.01 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $444.30 million by 2027. Contract Research and Manufacturing Organizations segment represented US $40.92 million opportunity over 2019-2021 and estimated to create US $334.38 million opportunity in 2027 over 2021.
R&D Departments
R&D Departments segment was valued at US $34.12 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $219.66 million by 2027. R&D Departments segment represented US $20.23 million opportunity over 2019-2021 and estimated to create US $165.31 million opportunity in 2027 over 2021.
Other End Users
Other End Users segment was valued at US $40.27 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $259.29 million by 2027. Other End Users segment represented US $23.88 million opportunity over 2019-2021 and estimated to create US $195.14 million opportunity in 2027 over 2021.
Region
Introduction
In 2021, North America segment has the highest revenue of US $195.30 million and is expected to grow at CAGR of 22.99% by 2027 North America segment has highest cagr growth of 22.99%.
North America
North America segment was valued at US $122.60 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $789.39 million by 2027. North America segment represented US $72.70 million opportunity over 2019-2021 and estimated to create US $594.09 million opportunity in 2027 over 2021.
Europe
Europe segment was valued at US $69.87 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $449.88 million by 2027. Europe segment represented US $41.43 million opportunity over 2019-2021 and estimated to create US $338.58 million opportunity in 2027 over 2021.
Asia Pacific
Asia Pacific segment was valued at US $55.82 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $359.38 million by 2027. Asia Pacific segment represented US $33.09 million opportunity over 2019-2021 and estimated to create US $270.47 million opportunity in 2027 over 2021.
Rest of the World
Rest of the World segment was valued at US $32.39 million in 2019 and is projected to grow at 22.99% CAGR over the forecast period to reach US $208.55 million by 2027. Rest of the World segment represented US $19.21 million opportunity over 2019-2021 and estimated to create US $156.95 million opportunity in 2027 over 2021.